Who
Ying Huang
Chief Executive Officer
Company insider
Files Form 4 as: Chief Executive Officer, Legend Biotech.
In numbers
- Trades disclosed
- 6
- Buys
- 0
- Sells
- 2
- Bought
- $0
- Sold
- $339K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 25 Mar 2026
- Last trade
- 30 Jun 2026
- Last filed
- 2 Jul 2026
Companies traded
Activity over time
1 Mar – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 30 Jun 2026filed 2 Jul 2026 | LEGN Legend BiotechBiotechnology | SEC FORM 4 Code G | —3,382 at $0.00 | filing |
| 30 Jun 2026filed 2 Jul 2026 | LEGN Legend BiotechBiotechnology | SEC FORM 4 Code G | —3,382 at $0.00 | filing |
| 25 Jun 2026filed 29 Jun 2026 | LEGN Legend BiotechBiotechnology | SEC FORM 4 Sold | $82K5,566 at $14.78 | filing |
| 25 Jun 2026filed 29 Jun 2026 | LEGN Legend BiotechBiotechnology | SEC FORM 4 Sold | $82K5,566 at $14.78 | filing |
| 25 Mar 2026filed 27 Mar 2026 | LEGN Legend BiotechBiotechnology | SEC FORM 4 Sold | $87K9,936 at $8.77 | filing |
| 25 Mar 2026filed 27 Mar 2026 | LEGN Legend BiotechBiotechnology | SEC FORM 4 Sold | $87K9,936 at $8.77 | filing |
News
Contrasting Legend Biotech (NASDAQ:LEGN) & Connect Biopharma (NASDAQ:CNTB)LEGN · tickerreport.com · 13 Oct 2026
0 headlines in the last 90 days name Ying Huang; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.